Fidelity Investments
OM icon

Fidelity Investments’s Outset Medical OM Stock Holding History

Fidelity Investments’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Buy
2,742,887
+1,214
+0% +$5.31K ﹤0.01% 2057
2026
Q1 		$10.5M Buy
2,741,673
+100,871
+4% +$413K ﹤0.01% 2024
2025
Q4 		$9.8M Sell
2,640,802
-23,996
-0.9% -$206K ﹤0.01% 2039
2025
Q3 		$37.6M Buy
2,664,798
+64,413
+2% +$1M ﹤0.01% 1539
2025
Q2 		$50M Buy
2,600,385
+3,524
+0.1% +$55K ﹤0.01% 1398
2025
Q1 		$28.7M Buy
2,596,861
+2,352,113
+961% +$28M ﹤0.01% 1563
2024
Q4 		$4.08M Sell
244,748
-73,504
-23% -$917K ﹤0.01% 2230
2024
Q3 		$3.23M Sell
318,252
-194,876
-38% -$5.8M ﹤0.01% 2263
2024
Q2 		$29.6M Buy
513,128
+49,937
+11% +$2.45M ﹤0.01% 1512
2024
Q1 		$15.4M Sell
463,191
-7,928
-2% -$401K ﹤0.01% 1744
2023
Q4 		$38.2M Sell
471,119
-26,783
-5% -$2.18M ﹤0.01% 1395
2023
Q3 		$81.3M Buy
497,902
+5,621
+1% +$1.33M 0.01% 1058
2023
Q2 		$161M Buy
492,281
+5,910
+1% +$1.8M 0.01% 807
2023
Q1 		$134M Buy
486,371
+3,292
+0.7% +$1.21M 0.01% 881
2022
Q4 		$187M Buy
483,079
+3,006
+0.6% +$848K 0.02% 708
2022
Q3 		$115M Buy
480,073
+2,130
+0.4% +$570K 0.01% 907
2022
Q2 		$107M Buy
477,943
+3,829
+0.8% +$1.65M 0.01% 948
2022
Q1 		$323M Buy
474,114
+3,171
+0.7% +$1.91M 0.03% 597
2021
Q4 		$326M Buy
470,943
+7,811
+2% +$5.78M 0.02% 607
2021
Q3 		$343M Buy
463,132
+3,318
+0.7% +$2.26M 0.03% 573
2021
Q2 		$345M Buy
459,814
+31,756
+7% +$24.3M 0.03% 591
2021
Q1 		$349M Buy
428,058
+1,052
+0.2% +$812K 0.03% 566
2020
Q4 		$351M Buy
427,006
+3,723
+0.9% +$2.87M 0.03% 518
2020
Q3 		$294M Buy
+423,283
New +$348M 0.03% 488

Other funds holding OM

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Fidelity Investments's OM Position: Q2 2026 in Review

Fidelity Investments increased its Outset Medical (OM) stake by 0.04% in Q2 2026, buying an estimated $5.31K and bringing the position to 2,742,887 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

Fidelity Investments first reported a position in OM in Q3 2020 and has held it in 24 quarters since. The position peaked at $351M in Q4 2020. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Fidelity Investments held 2,742,887 shares of Outset Medical worth $11.8M as of Q2 2026.
  • Fidelity Investments bought 1,214 Outset Medical shares in Q2 2026, an estimated $5.31K.
  • Outset Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2057 holding.
  • Fidelity Investments first reported a position in Outset Medical in Q3 2020 and has held it in 24 quarters since.
  • Fidelity Investments's Outset Medical position peaked at $351M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.